etiolog
agent
sever
acut
respiratori
syndrom
sar
emerg
worldwid
identifi
novel
type
coronaviru
sarscov
consist
singlestrand
positivesens
rna
genom
nucleotid
encod
rnadirect
rna
polymeras
structur
protein
includ
spike
envelop
e
membran
nucleocapsid
n
protein
marra
et
al
rota
et
al
ruan
et
al
n
protein
alkalin
protein
short
lysinerich
region
suggest
nuclear
local
signal
play
import
role
process
viru
particl
assembl
envelop
entir
genom
rna
marra
et
al
sarscov
n
protein
suggest
potent
antigen
earli
diagnosi
sarscov
infect
timani
et
al
moreov
recent
evid
indic
n
protein
induc
tcell
respons
sarscov
infect
gao
et
al
thu
n
protein
also
import
develop
effect
vaccin
sarscov
infect
edibl
conveni
lactic
acid
bacteria
lab
safe
use
food
industri
centuri
consid
potenti
mucos
deliveri
vehicl
vaccin
antigen
diey
et
al
gilbert
et
al
robinson
et
al
labbas
vaccin
effect
achiev
mucos
system
immun
mucos
site
entri
rout
mani
pathogen
includ
sarscov
hiv
instanc
lactococcu
lacti
use
vaccin
deliveri
system
hiv
env
protein
oral
administr
recombin
vaccin
antigen
induc
strong
hivspecif
humor
cellmedi
immun
respons
significantli
reduc
viral
load
follow
challeng
envexpress
vaccinia
viru
xin
et
al
paper
report
highlevel
product
sarscov
n
protein
escherichia
coli
foodgrad
bacterium
l
lacti
potenti
applic
purifi
human
glutathion
stransferas
hgst
fuse
n
protein
hgstn
serodiagnosi
n
proteinproduc
l
lacti
mucos
vaccin
experiment
evalu
bacteri
strain
plasmid
use
work
list
tabl
e
coli
strain
grown
medium
induc
shake
l
lacti
strain
grown
medium
without
shake
describ
diey
et
al
xiang
et
al
necessari
antibiot
induc
ad
follow
e
coli
ampicillin
erythromycin
chloramphenicol
isopropyl
thiogalactos
iptg
mmol
l
lacti
erythromycin
nisin
ng
gener
molecular
biolog
techniqu
perform
use
standard
method
sambrook
et
al
unless
otherwis
indic
cdna
sarscov
nucleocapsid
gene
n
alway
amplifi
pcr
pfu
polymeras
use
plasmid
pxn
see
tabl
templat
primer
use
follow
gene
clone
procedur
list
tabl
express
character
n
protein
e
coli
three
differ
express
plasmid
construct
fig
first
one
n
gene
pcramplifi
primer
pcr
product
digest
bamhi
sali
clone
site
yield
fig
second
one
n
gene
amplifi
primer
clone
bamhisalilinear
gener
pgexn
fig
third
one
hgst
gene
amplifi
hgst
xiang
et
al
primer
digest
ndei
bamhi
time
n
gene
gener
pgexn
digest
bamhi
sali
two
dna
fragment
clone
togeth
ndei
sali
site
result
plasmid
fig
plasmid
transform
e
coli
n
protein
product
andor
purif
express
n
protein
cytoplasm
l
lacti
secret
cultur
medium
two
express
plasmid
also
construct
first
one
n
gene
amplifi
primer
digest
ncoi
xbai
clone
site
gener
pcytn
nisininduc
product
n
protein
fig
second
one
n
gene
pcramplifi
primer
clone
plasmid
diey
et
al
sali
ecorv
site
result
plasmid
psecn
secret
n
protein
fig
two
express
plamid
pcytn
psecn
first
establish
e
coli
transfer
electropor
l
lacti
respect
describ
xiang
et
al
e
coli
harbor
express
plasmid
cultur
midexponenti
phase
optic
densiti
nm
induc
iptg
mm
addit
h
shake
rpm
cell
collect
pellet
resuspend
te
buffer
mm
trishcl
mm
edta
sucros
ph
sonic
min
complet
lyse
fusion
protein
hgstn
gener
gstn
gener
pgexn
purifi
column
amersham
bioscienc
accord
method
describ
xiang
et
al
antiserum
prepar
approxim
mg
purifi
gstn
mix
freund
complet
adjuv
inject
healthi
new
zealand
rabbit
three
time
per
week
antiserum
collect
margin
vein
rabbit
ear
day
use
western
blot
analysi
purifi
hgstn
protein
ng
dissolv
coat
buffer
mm
mm
ph
ad
micropl
ngwell
incub
overnight
well
block
nonfat
milk
pb
buffer
mm
nacl
mm
kcl
mm
mm
ph
incub
h
room
temperatur
wash
three
time
pb
dri
h
detect
nspecif
antibodi
sera
sar
patient
sera
dilut
load
well
triplic
incub
min
well
wash
pb
afterward
incub
peroxidaseconjug
rabbit
antihuman
antibodi
igg
addit
min
well
wash
pb
contain
peroxidas
reaction
perform
use
ophenylenediamin
substrat
min
reaction
stop
ad
well
read
comparison
sampl
assay
wide
use
commerci
avail
enzymelink
immunosorb
assay
elisa
kit
base
sarscov
viral
protein
mixtur
prepar
beij
genom
institut
chines
academi
scienc
cutoff
valu
defin
averag
control
sampl
plu
express
n
protein
cytoplasm
l
lacti
cultur
induc
nisin
ng
sigma
midexponenti
phase
h
cell
harvest
resuspend
te
buffer
protein
extract
sonic
secret
n
protein
l
lacti
recombin
strain
l
lacti
cultiv
lateexponenti
phase
protein
medium
cell
separ
prepar
describ
piard
et
al
diey
et
al
minor
modif
briefli
supernat
medium
part
cultur
filter
pore
size
filter
millipor
protein
filtrat
precipit
icecold
trichloroacet
acid
final
concentr
result
pellet
ml
filtrat
dissolv
water
analysi
contrast
cell
pellet
cultur
wash
resuspend
te
protein
extract
sonic
western
blot
analysi
protein
extract
subject
sdspage
acrylamid
sarscov
n
protein
express
l
lacti
detect
nspecif
antisera
gener
gstn
experi
n
protein
express
e
coli
use
control
protein
electroblot
antibodi
reaction
detect
perform
describ
wei
et
al
recombin
strain
l
lacti
control
strain
grown
harvest
describ
cell
resuspend
steril
pb
obtain
concentr
cell
strain
supernat
cultur
contain
secret
n
protein
collect
filter
describ
protein
ml
filtrat
concentr
ml
freezeevapor
cell
pellet
dilut
directli
pb
achiev
concentr
cell
ml
secret
n
protein
ml
cell
ml
combin
ml
mous
vaccin
six
group
balbc
femal
mice
five
mice
group
immun
oral
intranas
recombin
strain
control
strain
purifi
hgstn
resuspend
pb
respect
oral
dose
hgstn
cell
l
lacti
cell
freshli
prepar
describ
administ
oral
day
intranas
dose
hgstn
cell
describ
slowli
administ
mice
day
anoth
nonimmun
control
group
maintain
condit
immun
sera
collect
retroorbit
punctur
collect
day
final
immun
use
evalu
immunogen
recombin
l
lacti
strain
purifi
hgstn
use
elisa
describ
fulllength
fragment
n
gene
clone
express
e
coli
use
two
differ
express
plasmid
pgexn
describ
fig
tabl
insert
plasmid
sequenc
prove
correct
induct
iptg
hgstn
e
gstn
e
colipgexn
overexpress
expect
size
kda
kda
respect
fig
supernat
pellet
extract
prepar
sonic
centrifug
respect
subject
sdspage
also
determin
recombin
n
protein
solubl
rather
form
inclus
bodi
data
shown
allow
conveni
purifi
recombin
protein
within
supernat
inde
solubl
gstn
hgstn
success
purifi
singl
step
glutathionebas
affin
chromatographi
fig
polyclon
antibodi
prepar
rabbit
use
gstn
immunogen
verifi
specif
antibodi
sarscov
n
protein
protein
hgst
hgst
hgstn
gstn
subject
sdspage
western
blot
analysi
hgstn
kda
gstn
kda
gave
strong
signal
hgst
fig
result
clearli
indic
nspecif
antibodi
success
induc
gstn
antigen
significantli
recogn
hgstn
hgst
moreov
impli
hgstn
protein
might
effect
antigen
detect
nspecif
antibodi
sar
patient
investig
possibl
use
hgstn
diagnosi
sarscov
infect
elisa
assay
see
materi
method
perform
sera
collect
eight
sarscov
infect
patient
day
fever
onset
use
purifi
hgstn
antigen
sera
collect
healthi
peopl
control
shown
fig
sera
sar
patient
signific
posit
respons
hgstn
protein
none
control
sera
gave
posit
signal
result
also
achiev
commerci
avail
elisa
kit
coat
mixtur
sarscov
viral
protein
indic
igg
antibodi
n
protein
commonli
present
sera
sar
patient
detect
least
earli
day
fever
onset
moreov
result
provid
rapid
effici
strategi
product
purif
recombin
n
protein
serodiagnosi
sarscov
infect
sarscov
n
protein
also
consid
import
antigen
vaccin
develop
especi
adjuv
vaccin
antigen
protein
major
vaccin
antigen
induc
neutral
antibodi
gao
et
al
easi
use
protein
mucos
vaccin
express
protein
foodgrad
bacterium
l
lacti
first
product
recombin
sarscov
n
protein
l
lacti
analyz
nisin
induct
protein
extract
cytoplasm
medium
subject
sdspage
follow
western
blot
assay
antin
antibodi
prepar
absenc
nisin
signal
detect
indic
recombin
n
protein
produc
data
shown
h
induct
nisin
result
show
recombin
n
protein
present
cell
cytoplasm
fraction
expect
fig
howev
express
level
n
protein
strain
usual
subject
variabl
induct
effici
overcom
inconveni
construct
novel
recombin
strain
l
lacti
harbor
express
plasmid
psecn
n
gene
fuse
code
sequenc
signal
peptid
control
constitut
l
lacti
promot
western
blot
show
promin
band
kda
correspond
size
matur
n
protein
observ
medium
indic
sarscov
n
protein
secret
recombin
l
lacti
strain
secret
n
protein
degrad
fig
howev
nearli
n
protein
precursor
still
cytoplasm
fraction
fig
thu
express
recombin
n
protein
cytoplasm
medium
realiz
strain
l
lacti
render
suitabl
oral
intranas
administr
thirti
mice
randomli
divid
six
group
five
mice
group
administ
oral
intranas
strain
strain
purifi
hgstn
effect
immun
product
nspecif
igg
examin
elisa
day
final
administr
use
purifi
gstn
hgstn
antigen
exclud
interfer
hgst
result
indic
oral
administr
induc
signific
respons
nspecif
igg
sera
p
ttest
howev
oral
administr
purifi
hgstn
seem
induc
nspecif
respons
gave
background
signal
elisa
inspect
control
strain
fig
indic
n
protein
protect
gastric
tract
could
releas
intestin
mucos
site
purifi
hgstn
might
degrad
gastrointestin
environ
reach
mucos
site
also
intranas
administ
hgstn
investig
elicit
weak
nspecif
immun
signific
p
ttest
data
shown
sinc
sar
broke
research
made
great
effort
develop
fast
accur
analyt
method
earli
diagnosi
develop
safe
effici
vaccin
reemerg
although
mani
elisa
diagnost
kit
invent
base
viral
protein
mixtur
seem
conveni
prepar
requir
cultiv
sarscov
thu
alter
simpl
sensit
specif
n
proteinbas
elisa
investig
mani
laboratori
liu
et
al
timani
et
al
woo
et
al
investig
suggest
n
protein
immunodomin
perfect
diagnost
antigen
purpos
develop
simpl
way
express
purifi
sarscov
n
protein
fusion
human
gst
protein
purifi
hgstn
protein
use
coat
antigen
elisa
assay
serodiagnosi
sarscov
infect
show
high
level
sensit
posit
eight
test
sar
patient
specif
neg
test
healthi
peopl
also
elisa
signal
even
better
commerci
kit
fig
hgstn
protein
purifi
singl
step
fuse
human
gst
believ
gener
antibodi
human
sera
thu
provid
signific
option
use
serodiagnosi
sarscov
infect
sarscov
n
protein
also
report
import
enhanc
antibodi
product
gener
specif
cytotox
lymphocyt
ctl
suggest
n
proteininduc
ctl
might
play
import
role
clear
infect
cell
therebi
decreas
rate
pathogen
replic
mucos
epithelium
gao
et
al
zhu
et
al
sinc
sarscov
infect
mucos
membran
oral
intranas
vaccin
might
improv
protect
effici
thu
two
strategi
mucos
vaccin
n
protein
investig
work
one
use
purifi
hgstn
vaccin
antigen
use
nexpress
l
lacti
live
vaccin
first
one
sinc
hgst
safe
human
be
hgstn
accept
human
vaccin
howev
effici
dosag
hgstn
mean
administr
remain
investig
second
one
sinc
l
lacti
foodgrad
lab
also
acid
bileresist
might
good
choic
vehicl
n
protein
oral
vaccin
reveal
oral
administr
recombin
l
lacti
induc
signific
nspecif
antibodi
fig
much
effici
oral
intranas
administr
purifi
hgstn
impli
l
lacti
suitabl
vehicl
deliveri
n
protein
intestin
mucos
site
thu
express
sarscov
antigen
l
lacti
might
provid
novel
vaccin
cours
immunogen
vaccin
still
low
ctl
respons
protect
function
includ
use
adjuv
antigen
sarscov
proteinbas
mucos
vaccin
remain
investig
summari
success
achiev
express
purif
sarscov
n
protein
fusion
human
gst
e
coli
hgstn
show
potenti
use
option
serodiagnosi
sarscov
infect
also
construct
recombin
l
lacti
express
n
protein
oral
administr
nproduc
l
lacti
induc
nspecif
antibodi
mous
sera
result
provid
novel
strategi
crucial
inform
produc
sarscov
n
protein
diagnost
antigen
mucos
vaccin
